Ibrance (palbociclib) is an oral medication used to treat certain types of advanced or metastatic breast cancer (cancer that has spread to other parts of the body). It works by stopping the uncontrolled growth of cancer cells. Ibrance (palbociclib) is taken once a day for 21 days in a 28 day cycle. But it should be used in combination with other medications that block or lower the amount of estrogen in your body.
HR+/HER2- advanced or metastatic breast cancer
Ibrance (palbociclib) is a specific type of kinase inhibitor, called a cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitor. CDK 4/6 are proteins that control cell growth in both normal and cancer cells. These proteins can become overactive in cancer cells and cause the cancer to uncontrollably divide and grow. By blocking CDK 4/6, Ibrance (palbociclib) slows the growth of cancer cells.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Available as a pill that’s swallowed once a day
Recommended treatment option for breast cancer HR+, HER- advanced or metastatic breast cancer
Compared with other similar medications, causes less diarrhea and has lower risk of affecting your heart rhythm
Only available as a brand medication so it might be expensive
Can cause infections, some of which can be serious
Not safe to take while pregnant or breastfeeding
If you're taking the capsule form of Ibrance (palbociclib), take it with food at the same time every day. This helps more of the medication get absorbed in your body. If you’re taking the tablet form, you can take it with or without food.
If you miss a dose of Ibrance (palbociclib), or vomit after taking a dose, don’t take another dose that day. Take your next dose at the normally scheduled time.
Avoid grapefruit and grapefruit juice while taking Ibrance (palbociclib). These foods or drinks can raise the levels of the medication in your body and raise your risk for more side effects.
Certain medications can interact with Ibrance (palbociclib), so it’s important to tell your provider and pharmacist about all the medications you take, including supplements and over-the-counter (OTC) medications. Your provider can guide you to safer alternatives or recommend how to best take your medications.
You should be taking Ibrance (palbociclib) at the same time as a medication that blocks or lowers the amount of estrogen in your body (like an aromatase inhibitor or fulvestrant [Faslodex]). Check with your provider if you aren’t receiving one of these medications.
Ask your provider or pharmacist about the best way to handle and throw away Ibrance (palbociclib) safely. Anticancer medications can be very harmful to people who handle or come into contact with them.
Ibrance (palbociclib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Ibrance (palbociclib) can cause your white blood cell count to drop. When these cell counts are lower than normal, you might be at risk of developing infections. Your provider will check your blood counts often while you’re taking Ibrance (palbociclib). Let your provider know if you develop a fever or start to feel sick. If this happens you might need to have your dose lowered or stop this medication all together.
Rarely, Ibrance (palbociclib) can cause serious lung problems, like inflammation of your lungs or interstitial lung disease. Let your provider know if you develop any new or worsening breathing problems (e.g., shortness of breath, dry cough, or breathing faster). Your provider might tell you to stop taking Ibrance (palbociclib) while they figure out what’s causing the lung problems.
Based on animal studies, Ibrance (palbociclib) can harm an unborn baby. Because of this risk, females of childbearing age should use birth control while taking Ibrance (palbociclib) and for at least 3 weeks after the last dose. Males with female partners of childbearing age should use birth control while taking Ibrance (palbociclib) and for at least 3 months after the last dose. Let your provider know right away if you become pregnant during this time.
Ibrance (palbociclib) is taken in a cycle of 28 days. For the first 21 days of the cycle, the typical dose is 125 mg taken by mouth once a day. During the last 7 days of the cycle, you won't take any Ibrance (palbociclib). At the end of the 28 days, the cycle typically starts over again.
Your dose might be different if you have liver problems or if you’re taking medications that might interact with Ibrance (palbociclib) (see Pharmacist Tips).
You’ll also need to take either an aromatase inhibitor or fulvestrant (Faslodex) for treatment. In addition, if you’re a male or a female who hasn’t undergone menopause, your provider might also recommend you take a luteinizing hormone-releasing hormone (LHRH) agonist.
Early breast cancer in people with a high risk of their cancer coming back
Advanced or metastatic breast cancer
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.